Article info

Download PDFPDF

Original article
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

Authors

  1. Correspondence to Dr. Joel M Kremer, Albany Medical College and The Center forRheumatology, Albany, New York, USA; jkremer{at}joint-docs.com
View Full Text

Citation

Kremer JM, Schiff M, Muram D, et al
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

Publication history

  • Received September 18, 2017
  • Revision received December 4, 2017
  • Accepted December 6, 2017
  • First published January 13, 2018.
Online issue publication 
January 17, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.